List of Tables
Table 1. Global VMAT2 Inhibitors Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global VMAT2 Inhibitors Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global VMAT2 Inhibitors Market Competitive Situation by Manufacturers in 2024
Table 4. Global VMAT2 Inhibitors Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global VMAT2 Inhibitors Sales Market Share by Manufacturers (2020-2025)
Table 6. Global VMAT2 Inhibitors Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global VMAT2 Inhibitors Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market VMAT2 Inhibitors Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of VMAT2 Inhibitors, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of VMAT2 Inhibitors, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of VMAT2 Inhibitors, Product Type & Application
Table 12. Global Key Manufacturers of VMAT2 Inhibitors, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global VMAT2 Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in VMAT2 Inhibitors as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global VMAT2 Inhibitors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global VMAT2 Inhibitors Sales by Region (2020-2025) & (K Units)
Table 18. Global VMAT2 Inhibitors Sales Market Share by Region (2020-2025)
Table 19. Global VMAT2 Inhibitors Sales by Region (2026-2031) & (K Units)
Table 20. Global VMAT2 Inhibitors Sales Market Share by Region (2026-2031)
Table 21. Global VMAT2 Inhibitors Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global VMAT2 Inhibitors Revenue Market Share by Region (2020-2025)
Table 23. Global VMAT2 Inhibitors Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global VMAT2 Inhibitors Revenue Market Share by Region (2026-2031)
Table 25. North America VMAT2 Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America VMAT2 Inhibitors Sales by Country (2020-2025) & (K Units)
Table 27. North America VMAT2 Inhibitors Sales by Country (2026-2031) & (K Units)
Table 28. North America VMAT2 Inhibitors Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America VMAT2 Inhibitors Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe VMAT2 Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe VMAT2 Inhibitors Sales by Country (2020-2025) & (K Units)
Table 32. Europe VMAT2 Inhibitors Sales by Country (2026-2031) & (K Units)
Table 33. Europe VMAT2 Inhibitors Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe VMAT2 Inhibitors Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific VMAT2 Inhibitors Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific VMAT2 Inhibitors Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific VMAT2 Inhibitors Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific VMAT2 Inhibitors Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific VMAT2 Inhibitors Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America VMAT2 Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America VMAT2 Inhibitors Sales by Country (2020-2025) & (K Units)
Table 42. Latin America VMAT2 Inhibitors Sales by Country (2026-2031) & (K Units)
Table 43. Latin America VMAT2 Inhibitors Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America VMAT2 Inhibitors Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa VMAT2 Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa VMAT2 Inhibitors Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa VMAT2 Inhibitors Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa VMAT2 Inhibitors Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa VMAT2 Inhibitors Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global VMAT2 Inhibitors Sales (K Units) by Type (2020-2025)
Table 51. Global VMAT2 Inhibitors Sales (K Units) by Type (2026-2031)
Table 52. Global VMAT2 Inhibitors Sales Market Share by Type (2020-2025)
Table 53. Global VMAT2 Inhibitors Sales Market Share by Type (2026-2031)
Table 54. Global VMAT2 Inhibitors Revenue (US$ Million) by Type (2020-2025)
Table 55. Global VMAT2 Inhibitors Revenue (US$ Million) by Type (2026-2031)
Table 56. Global VMAT2 Inhibitors Revenue Market Share by Type (2020-2025)
Table 57. Global VMAT2 Inhibitors Revenue Market Share by Type (2026-2031)
Table 58. Global VMAT2 Inhibitors Price (US$/Unit) by Type (2020-2025)
Table 59. Global VMAT2 Inhibitors Price (US$/Unit) by Type (2026-2031)
Table 60. Global VMAT2 Inhibitors Sales (K Units) by Application (2020-2025)
Table 61. Global VMAT2 Inhibitors Sales (K Units) by Application (2026-2031)
Table 62. Global VMAT2 Inhibitors Sales Market Share by Application (2020-2025)
Table 63. Global VMAT2 Inhibitors Sales Market Share by Application (2026-2031)
Table 64. Global VMAT2 Inhibitors Revenue (US$ Million) by Application (2020-2025)
Table 65. Global VMAT2 Inhibitors Revenue (US$ Million) by Application (2026-2031)
Table 66. Global VMAT2 Inhibitors Revenue Market Share by Application (2020-2025)
Table 67. Global VMAT2 Inhibitors Revenue Market Share by Application (2026-2031)
Table 68. Global VMAT2 Inhibitors Price (US$/Unit) by Application (2020-2025)
Table 69. Global VMAT2 Inhibitors Price (US$/Unit) by Application (2026-2031)
Table 70. Neurocrine Biosciences, Inc Company Information
Table 71. Neurocrine Biosciences, Inc Description and Business Overview
Table 72. Neurocrine Biosciences, Inc VMAT2 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Neurocrine Biosciences, Inc VMAT2 Inhibitors Product
Table 74. Neurocrine Biosciences, Inc Recent Developments/Updates
Table 75. Teva Pharmaceutical Industries Ltd Company Information
Table 76. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 77. Teva Pharmaceutical Industries Ltd VMAT2 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Teva Pharmaceutical Industries Ltd VMAT2 Inhibitors Product
Table 79. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 80. Sun Pharmaceutical Industries Ltd Company Information
Table 81. Sun Pharmaceutical Industries Ltd Description and Business Overview
Table 82. Sun Pharmaceutical Industries Ltd VMAT2 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Sun Pharmaceutical Industries Ltd VMAT2 Inhibitors Product
Table 84. Sun Pharmaceutical Industries Ltd Recent Developments/Updates
Table 85. Hikma Pharmaceuticals plc Company Information
Table 86. Hikma Pharmaceuticals plc Description and Business Overview
Table 87. Hikma Pharmaceuticals plc VMAT2 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Hikma Pharmaceuticals plc VMAT2 Inhibitors Product
Table 89. Hikma Pharmaceuticals plc Recent Developments/Updates
Table 90. Hetero Company Information
Table 91. Hetero Description and Business Overview
Table 92. Hetero VMAT2 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Hetero VMAT2 Inhibitors Product
Table 94. Hetero Recent Developments/Updates
Table 95. Bausch Health Companies Inc Company Information
Table 96. Bausch Health Companies Inc Description and Business Overview
Table 97. Bausch Health Companies Inc VMAT2 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Bausch Health Companies Inc VMAT2 Inhibitors Product
Table 99. Bausch Health Companies Inc Recent Developments/Updates
Table 100. Dr. Reddy's Laboratories Ltd Company Information
Table 101. Dr. Reddy's Laboratories Ltd Description and Business Overview
Table 102. Dr. Reddy's Laboratories Ltd VMAT2 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Dr. Reddy's Laboratories Ltd VMAT2 Inhibitors Product
Table 104. Dr. Reddy's Laboratories Ltd Recent Developments/Updates
Table 105. Piramal Pharma Solution Company Information
Table 106. Piramal Pharma Solution Description and Business Overview
Table 107. Piramal Pharma Solution VMAT2 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Piramal Pharma Solution VMAT2 Inhibitors Product
Table 109. Piramal Pharma Solution Recent Developments/Updates
Table 110. Lupin Company Information
Table 111. Lupin Description and Business Overview
Table 112. Lupin VMAT2 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Lupin VMAT2 Inhibitors Product
Table 114. Lupin Recent Developments/Updates
Table 115. Luye Pharma Group Company Information
Table 116. Luye Pharma Group Description and Business Overview
Table 117. Luye Pharma Group VMAT2 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Luye Pharma Group VMAT2 Inhibitors Product
Table 119. Luye Pharma Group Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. VMAT2 Inhibitors Distributors List
Table 123. VMAT2 Inhibitors Customers List
Table 124. VMAT2 Inhibitors Market Trends
Table 125. VMAT2 Inhibitors Market Drivers
Table 126. VMAT2 Inhibitors Market Challenges
Table 127. VMAT2 Inhibitors Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of VMAT2 Inhibitors
Figure 2. Global VMAT2 Inhibitors Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global VMAT2 Inhibitors Market Share by Type: 2024 & 2031
Figure 4. Tetrabenazine Product Picture
Figure 5. Valbenazine Product Picture
Figure 6. Other Product Picture
Figure 7. Global VMAT2 Inhibitors Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global VMAT2 Inhibitors Market Share by Application: 2024 & 2031
Figure 9. Huntington’s Disease
Figure 10. Tardive Dyskinesia
Figure 11. Other
Figure 12. Global VMAT2 Inhibitors Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global VMAT2 Inhibitors Market Size (2020-2031) & (US$ Million)
Figure 14. Global VMAT2 Inhibitors Sales (2020-2031) & (K Units)
Figure 15. Global VMAT2 Inhibitors Average Price (US$/Unit) & (2020-2031)
Figure 16. VMAT2 Inhibitors Report Years Considered
Figure 17. VMAT2 Inhibitors Sales Share by Manufacturers in 2024
Figure 18. Global VMAT2 Inhibitors Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest VMAT2 Inhibitors Players: Market Share by Revenue in VMAT2 Inhibitors in 2024
Figure 20. VMAT2 Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global VMAT2 Inhibitors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America VMAT2 Inhibitors Sales Market Share by Country (2020-2031)
Figure 23. North America VMAT2 Inhibitors Revenue Market Share by Country (2020-2031)
Figure 24. United States VMAT2 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada VMAT2 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe VMAT2 Inhibitors Sales Market Share by Country (2020-2031)
Figure 27. Europe VMAT2 Inhibitors Revenue Market Share by Country (2020-2031)
Figure 28. Germany VMAT2 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France VMAT2 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. VMAT2 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy VMAT2 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia VMAT2 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific VMAT2 Inhibitors Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific VMAT2 Inhibitors Revenue Market Share by Region (2020-2031)
Figure 35. China VMAT2 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan VMAT2 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea VMAT2 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India VMAT2 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia VMAT2 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan VMAT2 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Southeast Asia VMAT2 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America VMAT2 Inhibitors Sales Market Share by Country (2020-2031)
Figure 43. Latin America VMAT2 Inhibitors Revenue Market Share by Country (2020-2031)
Figure 44. Mexico VMAT2 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil VMAT2 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina VMAT2 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa VMAT2 Inhibitors Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa VMAT2 Inhibitors Revenue Market Share by Country (2020-2031)
Figure 49. Turkey VMAT2 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia VMAT2 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE VMAT2 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of VMAT2 Inhibitors by Type (2020-2031)
Figure 53. Global Revenue Market Share of VMAT2 Inhibitors by Type (2020-2031)
Figure 54. Global VMAT2 Inhibitors Price (US$/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of VMAT2 Inhibitors by Application (2020-2031)
Figure 56. Global Revenue Market Share of VMAT2 Inhibitors by Application (2020-2031)
Figure 57. Global VMAT2 Inhibitors Price (US$/Unit) by Application (2020-2031)
Figure 58. VMAT2 Inhibitors Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
